Richard Marlink
Overview
Explore the profile of Richard Marlink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Swart N, Lebelonyane R, Gutterman E, Legwaila M, Friebel-Klingner T, Antony R, et al.
JCO Glob Oncol
. 2024 Sep;
10:e2400196.
PMID: 39348622
Purpose: The growing cancer burden in Botswana has been linked to aging, lifestyle factors, and high HIV infection prevalence. The government has designated four geographically distributed hospitals as public oncology...
2.
Ngwa W, Pressley A, Wilson V, Marlink R, Quintana Y, Chipidza F, et al.
Nat Med
. 2024 Jul;
30(9):2388-2389.
PMID: 39009778
No abstract available.
3.
Anderson M, Phinius B, Phakedi B, Mudanga M, Bhebhe L, Tlhabano G, et al.
Front Microbiol
. 2024 May;
15:1342862.
PMID: 38784816
Aim: This study aimed to determine the kinetics of occult hepatitis B virus infections (OBI) among people with HIV (PWH). Methods: The study used archived plasma samples from longitudinal HIV...
4.
Sharma K, Baghirova-Busang L, Abkenari S, Gulubane G, Rana C, Vuylsteke P, et al.
J Cancer Policy
. 2023 Oct;
38:100449.
PMID: 37890667
Background: New models of care are required to support women with breast cancer due to rising incidence and mortality in sub-Saharan Africa (SSA). This study gives voice to the experiences...
5.
Sharma K, Mayer T, Li S, Qureshi S, Farooq F, Vuylsteke P, et al.
PLOS Glob Public Health
. 2023 Jun;
3(6):e0001653.
PMID: 37368872
Cancer incidence is rising across sub-Saharan Africa (SSA), and is often characterized by late-stage presentation, early age of onset and poor survival. While a number of oncology drugs are now...
6.
Popli P, Gutterman E, Omene C, Ganesan S, Mills D, Marlink R
JCO Glob Oncol
. 2021 Feb;
7:289-301.
PMID: 33591798
Purpose: Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) are determinants of treatment and mortality for patients with breast cancer (BC). In East Africa, the...
7.
Nthobatsang K, Ncenga T, Mwangi-Woto C, Wedu T, Gabatlhaolwe T, Moyo S, et al.
AIDS
. 2021 Jan;
35(5):769-776.
PMID: 33394678
Objective: To evaluate the association between the Rhesus system RH2-blood group expression and susceptibility to HIV infection, viral load, CD4+ cell count and rate of CD4+ decline. We also aimed...
8.
Phinius B, Anderson M, Bhebhe L, Baruti K, Manowe G, Choga W, et al.
Pathogens
. 2020 Nov;
9(11).
PMID: 33202597
People with concomitant human immunodeficiency virus (HIV) and tuberculosis (TB) have an increased risk of hepatotoxic reactions due to antiretroviral therapy (ART) and anti-TB therapy (ATT). Concomitant hepatitis B virus...
9.
Phinius B, Anderson M, Bokete R, Mbangiwa T, Choga W, Baruti K, et al.
Medicine (Baltimore)
. 2020 Mar;
99(9):e19341.
PMID: 32118769
Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection is highest in sub-Saharan Africa and results in accelerated clinical outcomes compared with HBV or HIV mono-infection. HBV clearance rates...
10.
Anderson M, Choga W, Moyo S, Bell T, Mbangiwa T, Phinius B, et al.
Genes (Basel)
. 2018 Sep;
9(9).
PMID: 30205537
The World Health Organization plans to eliminate hepatitis B and C Infections by 2030. Therefore, there is a need to study and understand hepatitis B virus (HBV) epidemiology and viral...